/CNVCF
CNVCF Stock - BioHarvest Sciences Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$6.30+0.00%
59
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.60
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $6.93
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CNVCF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$6.24 – $6.36
TARGET (TP)$7.24
STOP LOSS$5.80
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.49
52W High$6.30
52W Low$6.30
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $12.67M | $5.50M | $2.10M | $396,000 | $218,000 |
| Gross Profit | $5.63M | $1.22M | $670,000 | $138,000 | $29,000 |
| Gross Margin | 44.5% | 22.2% | 31.9% | 34.8% | 13.3% |
| Operating Income | $-9,966,000 | $-10,612,000 | $-8,491,000 | $-6,166,000 | $-2,310,000 |
| Net Income | $-12,564,000 | $-11,236,000 | $-9,827,000 | $-6,584,000 | $-5,310,000 |
| Net Margin | -99.1% | -204.4% | -467.5% | -1662.6% | -2435.8% |
| EPS | $-0.93 | $-0.86 | $-0.79 | $-0.68 | $-1.80 |
Company Overview
BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. Its plant cell growth technology produces the active secondary metabolites without the need to grow the plant itself. The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product; and medical cannabis. BioHarvest Sciences Inc. is based in Vancouver, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
CNVCFBeat Rate
50%
Last 2 quarters
Avg Surprise
-41.2%
EPS vs Estimate
Beats / Misses
1/1
Last 12 quarters
Latest EPS
$-0.12
Q4 2024
EPS Surprise History
Q4 22
No data
Q2 23
No data
Q2 23
No data
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
+60.0%
$-0.04vs$-0.10
Q4 24
-142.4%
$-0.12vs$-0.05
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Aug 27, 2025 | — | — | — | — |
Q2 2025 | May 28, 2025 | — | — | — | — |
Q4 2024 | Nov 14, 2024 | $-0.05 | $-0.12 | -142.4% | ✗ MISS |
Q3 2024 | Aug 29, 2024 | $-0.10 | $-0.04 | +60.0% | ✓ BEAT |
Q2 2024 | Apr 30, 2024 | — | $-0.70 | — | — |
Q1 2024 | Feb 26, 2024 | — | $-0.39 | — | — |
Q4 2023 | Nov 28, 2023 | — | $-0.10 | — | — |
Q2 2023 | May 30, 2023 | — | $-0.16 | — | — |
Q2 2023 | Apr 27, 2023 | — | $-0.04 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.16 | — | — |
Q4 2022 | Nov 28, 2022 | — | $-0.22 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.14 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.13 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.11 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.19 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.12 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.45 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.20 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.12 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.10 | — | — |
Latest News
BioHarvest Sciences Gets $1.6M Grant From Israeli Innovation Authority Under Bio-Convergence Program
📈 PositiveBenzinga•Dec 18, 2025, 12:37 PM•Also:
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
📈 PositiveBenzinga•Dec 18, 2025, 12:21 PM•Also: , ,
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
📈 PositiveBenzinga•Dec 17, 2025, 01:38 PM•Also: , ,
BioHarvest Sciences Rolls Out VINIA Blood Flow Hydration Solution In U.S.
📈 PositiveBenzinga•Dec 3, 2025, 12:33 PM•Also:
BioHarvest Sciences shares are trading lower after the company reported worse-than-expected Q3 financial results.
📉 NegativeBenzinga•Nov 13, 2025, 09:18 PM•Also:
BioHarvest Sciences Inc. - Common Stock Q3 EPS $(0.14) Misses $(0.12) Estimate, Sales $9.067M Miss $9.123M Estimate
📉 NegativeBenzinga•Nov 13, 2025, 09:04 PM•Also:
BioHarvest Sciences Prices 2,485,000 Shares Public Offering At $7/Share, Sees Gross Proceeds $17.4M
➖ NeutralBenzinga•Nov 7, 2025, 12:34 PM•Also:
BioHarvest Sciences announces proposed public offering; shares down
📉 NegativeSeeking Alpha•Nov 6, 2025, 10:43 PM•Also:
BioHarvest Sciences Announces Underwritten Public Offering; Terms Not Disclosed
➖ NeutralBenzinga•Nov 6, 2025, 09:55 PM•Also:
BioHarvest Enters Strategic CDMO Agreement With Saffron Tech To Revolutionize Global Saffron Production
📈 PositiveBenzinga•Oct 30, 2025, 11:45 AM•Also:
BioHarvest Raises $10.9M And Cuts $3.8M Debt In Major Balance Sheet Boost
📈 PositiveBenzinga•Sep 22, 2025, 10:36 AM•Also:
BioHarvest Produces Plant-Based Exosomes At Scale, Opening New Opportunities In Medicine And Skincare
📈 PositiveBenzinga•Sep 10, 2025, 11:03 AM•Also:
Bioharvest Sciences Files For Mixed Shelf Of Up To $100M
➖ NeutralBenzinga•Aug 28, 2025, 03:24 PM•Also:
Frequently Asked Questions about CNVCF
What is CNVCF's current stock price?
BioHarvest Sciences Inc. (CNVCF) is currently trading at $6.30 per share. The stock has moved +0.00% today.
What is the analyst price target for CNVCF?
No analyst price targets are currently available for this stock.
What sector is BioHarvest Sciences Inc. in?
BioHarvest Sciences Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is CNVCF's market cap?
BioHarvest Sciences Inc. has a market capitalization of $0.11 billion, making it a small-cap company.
Does CNVCF pay dividends?
No, BioHarvest Sciences Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorADOIF
Adocia S.A.
$8.87
Mkt Cap: $0.1B
AMEUF
Anteris Technologies Ltd
$5.70
Mkt Cap: $0.1B
COPHF
Creso Pharma Limited
$0.12
Mkt Cap: $0.1B
CSAMF
CSAM Health Group AS
$4.82
Mkt Cap: $0.1B
EOFBY
Ecofibre Limited
$0.84
Mkt Cap: $0.1B
EPRXF
Eupraxia Pharmaceuticals Inc.
$3.04
Mkt Cap: $0.1B
GREH
Green Rain Energy Holdings Inc.
$0.00
Mkt Cap: $0.0B
LFLY
Leafly Holdings, Inc.
$37.00
Mkt Cap: $0.1B
LPCUF
Lee's Pharmaceutical Holdings Limited
$0.19
Mkt Cap: $0.1B
RSHUF
Respiri Limited
$0.06
Mkt Cap: $0.1B
Explore stocks similar to CNVCF for comparison